r u m 25-OHD l e v e l s , t h e major c i r c u l a t i n g vitamin D m e t a b o l i t e , by a s p e c i f i c p r o t e i n binding assay. Fasting blood was obtained from 17 p a t i e n t s with proved p a n c r e a t i c i n s u f f i c i e n c y (PI) and 2 p a t i e n t s without PI aged 6-47 y e a r s . All p a t i e n t s with PI had received p a n c r e a t i c enzyme and multivitamin supplements. A l l pat i e n t s had normal serum Ca and P l e v e l s and none had radiographi c evidence of r i c k e t s o r osteomalacia. CF P a t i e n t s With PI (n=17) Without PI (n=2) Normal Carotene(pg/dl) 33 t 7(X t SE) 119; 85 50-300 Vitamin A(IU/dl)l30 ? 15 103; 207 65-275 25-ODH(ng/ml) 33.6t 60 59.3; 112.0 15-80 The mean 25-OHD l e v e l i n t h e lower range o f normal i n CF pat i e n t s with PI w i t h vitamin D supplementation i s s i m i l a r t o f i n d i n g s f o r o t h e r f a t s o l u b l e vitamins. 4 p a t i e n t s had l e v e l s below t h e normal range, with 1 being undetectable. CF p a t i e n t s without PI had high l e v e l s o f 25-OHD. The observed d i f f e r e n c e between t h e r e s u l t s i n our s t u d i e s a s s e s s i n g vitamin D s t a t u s i s a t l e a s t p a r t i a l l y a t t r i b u t a b l e t o t h e assay f o r 25-OHD being s p e c i f i c , whereas t h e bioassay i s n o n -s p e c i f i c and measures t h e sum o f t h e a c t i v i t i e s due t o vitamin D, and D, and t h e i r metabol i t e s . A 40% incidence o f abnormal G B s t u d i e s i s r e p o r t e d i n p a t i e n t with CF and i t i s thought t h a t t h e incidence i n c r e a s e s markedly with age. Also, e v a l u a t i o n o f t h e GB sometimes i n d i c a t e s t h e cause o f abdominal pain i n CF p a t i e n t s . Accordingly, we s t u d i e d a l l CF p a t i e n t s over 14 y e a r s o f age i n our c l i n i c . Results o f o r a l cholecystograms i n 31 CF p a t i e n t s a r e summarized. P a t i e n t Age ( y r ) X-ray Evaluation 14-17 18-20 21-47 T o t a l Normal 5(83%) 6(75%) 11(65%) 22(71%) Abnormal 1(17%) 2(25%) 6(35%) 9(29%) Nonvisualization 1 1 5 7(23%) C a l c u l i 0 1 1 2 (6%) 6 out o f t h e 7 p a t i e n t s with n o n v i s u a l i z a t i o n o f t h e GB underwen ultrasonography. The GB remained undetectable i n 4 and was small e r than normal (3 x lcm) i n 2. No c a l c u l i were seen on u l t r asound i n p a t i e n t s with n o n v i s u a l i z a t i o n on o r a l cholecystography jowever c a l c u l i were i d e n t i f i a b l e by ultrasonography i n p a t i e n t s known t o have c h o l e l i t h i a s i s . Our r e s u l t s i n d i c a t e t h a t althougk t h e incidence o f abnormal GB s t u d i e s i n c r e a s e s s l i g h t l y with age t h e o l d e r CF p a t i e n t does not have a s s i g n i f i c a n t l y increased r i s k o f GB d i s e a s e a s p r e v i o u s l y suspected (Am.J. Roentgenol.128: 953,1977) . Also, ultrasonography may be a u s e f u l t o o l i n t h e ev a l u a t i o n o f t h e CF p a t i e n t who p r e s e n t s with abdominal pain o f mknown e t i o l o g y , e s p e c i a l l y i n t h e r i g h t upper quadrant.
IVER ULTRASTRUCTURE: DISSIMILARITY BEWEEN REYE' S AND HERITABLE DEFECT OF CARBAMYL PHOSPHATE SE OR OmITHINE TRANSCARBAMYLASE. Geor e William Schubert. Dept . of Pediat-Cinc i n n a t i , OH and Columbia, MO. L i v e r i n Reye's syndrome (RS) i n d i c a t e s marked f a t t y i n f i lt r a t i o n and by electronmicroscopy (EM) i n mitochondria: ameboic d i s f i g u r a t i o n , v a r i a t i o n i n s i z e , m a t r i x r a r e f a c t i o n , a b s e n t granules. Biochemically i n RS, t h e two mitochondrial urea cycle enzymes (carbamyl phosphate synthetase(CPS), o r n i t h i n e t r a n scarbamylase(0TC))are t r a n s i e n t l y reduced t o 28 and 32% of normal. Whether CPS o r OTC r e d u c t i o n i s r e s p o n s i b l e f o r t h e a l t e red mitochondrial appearance was s t u d i e d by E M of l i v e r i n :
(A) h e r i t a b l e CPS d e f i c i e n c y (CPS<5%); and i n :
(B) h e r i t a b l e OTC d e f i c i e n c y (OTC<5%). EM-A i n d i c a t e d p l e t h o r a of Golgi apparat u s ; unusual l i p o f u s c i n bodies; l o s s of m i c r o v i l i i n d i l a t e d b i l e c a n a l i c u l i ; normal d e p o s i t s of l i p i d and glycogen and no mitochondrial changes.
EM-B i n d i c a t e d normal Golgi a p p a r a t u s ; minimal l i p i d and p l e n t i f u l glycogen d e p o s i t s ; few r e s i d u a l bodies; autophagic vacuoles; microbodies v a r y i n g widely i n s i z e (some ballooning) w i t h f l o c c u l a r m a t r i x and d i s i n t e g r a t i n g membranes; i n mitochondria: no enlargement; no ameboid d i s f i g u r at i o n o r m a t r i x r a r e f a c t i o n ; no granules.
I n summary: EM-A o r EM-B (though showing a b n o r m a l i t i e s ) was u n l i k e EM-RS.
Thus i n RS, CPS o r OTC r e d u c t i o n i s not l i k e l y t o cause t h e a l t e r e d m it o c h o n d r i a l appearance; r a t h e r t h e biochemical and E M changes may both be t h e consequence of a primary mitochondrial i n j u r y . The unusual amino a c i d 3-methylhistidine (3MH) i s p r e s e n t only i n muscle ( t h e major p r o t e i n mass i n the body). Urinary 3 M H i s an ideal i n d i c a t o r of p r o t e i n catabolism because t h e one mole of 3MH r e l e a s e d upon breakdown of each mole of a c t i n and myosin heavy chain i s excreted from t h e body without r e u t i l iz a t i o n . W e a r e p r e s e n t l y i n v e s t i g a t i n g t h e e f f e c t s o f parent e r a l n u t r i t i o n on t h e p r o t e i n n~e t a b o l i c s t a t e of neonates whose o r a l n u t r i e n t i n t a k e f o r various c l i n i c a l conditions i s inadequate.
In a preliminary study 17 3MH/creatinine r a t i o measurements were performed on s p o t u r i n e s i n 6 premature and 5 term i n f a n t s . The newborns who were healthy and growing were found t o have a r a t i o of 0.222+ 0.016 (mean and S.D. ) which value i s about twc times higher than t h a t of normal a d u l t s i n our population. The 3MH/creatinine r a t i o was s i g n i f i c a n t l y e l e v a t e d (range 0.270 -0.690; mean 0.377 + 143 S.D.) i n i n f a n t s who were l o s i n g weight and had low n u t r i e n t i n t a k e because of prematurity, s e p s i s o r p o s t o p e r a t i v e c o n d i t i o n . The r e l a t i v e l y high 3MH/creatinine r a t i o i n normal growing i n f a n t s i s c o n s i s t e n t with the e l e v a t e d metabolic r a t e and p r o t e i n turn over i n neonates. The r i s e i n t h e r a t i o s of s t r e s s e d i n f a n t s r e f l e c t s increased muscle p r o t e i n catabolism which i s a p p a r e n t l , secondary t o m a l n u t r i t i o n .
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CONCENTRATION OF CHOLESTEROL I N DIFFERENT BODY POOLS OF MINI-PIGS FED ATHEROGENIC AND CONTROL DIETS.
443 r--~M u s h t a q A. Khan, Alan J . Sheppard, Robert W . Mahley, F r a n c i s L. E a r l and F e l i x P. Heald, Dept. Ped. Univ. Md. Sch. Me Baltimore, Maryland 21201; Divisions of N u t r i t i o n 6 Toxicology, FDA, Washington, D.C. 20204 and NIH, Bethesda, Maryland 20014.
Relationships of d i e t a r y c h o l e s t e r o l t o i t s d i s t r i b u t i o n and d e p o s i t i o n i n v a r i o u s t i s s u e s were s t u d i e d i n male mini-pigs f e d i s o c a l o r i c a high cholesterol-high f a t (HC-HF) and c o n t r o l (C)
d i e t from 30 through 55 weeks (wks) of age. Cholesterol was meas ured i n serum a t a l t e r n a t e wks throughout the s t u d y ; i n lipoprot e i n f r a c t i o n s , l i v e r , muscle, and adipose t i s s u e a t t h e end of t h e experiment. Although c h o l e s t e r o l l e v e l s were higher i n a l l t i s s u e s of HC-HF group, a s t a t i s t i c a l l y s i g n i f i c a n t d i f f e r e n c e from t h e C group was observed only i n c a s e of c h o l e s t e r o l conten of l i v e r , serum and l i p o p r o t e i n f r a c t i o n s . LDL and HDLc c a r r i e d t h e h i g h e s t amounts of c h o l e s t e r o l i n the HC-HF group than t h e c o n t r o l s which had no HDLc. Cholesterol content of VLDL and HDL was a l s o s i g n i f i c a n t l y g r e a t e r i n t h e HC-HF animals than t h e C group. A 4-fold i n c r e a s e i n serum c h o l e s t e r o l was observed withi n 5 wks a f t e r feeding t h e HC-HF d i e t and a peak was reached w i t h i n 15 wks followed by a s i g n i f i c a n t d e c l i n e t o more o r l e s s constant l e v e l a f t e r 40 wks of age d e s p i t e a uniform d a i l y i n t a k of d i e t a r y c h o l e s t e r o l . I t seems t h a t t h e pig a f t e r 40 wks of ag a c q u i r e s some mechanism(s) t o e i t h e r metabolize d i e t a r y cholest e r o l more e f f e c t i v e l y o r t h e endogenous s y n t h e s i s of t h i s s t e ro i d i s decreased. (Supported from N I H g r a n t (NS 06779-08) and ?he e i f i c a c y of Viokase, Cotazvm and Pancrease on f a t and n lrogen absorptions were a s s e s s e d I n 12 c y s t i c f i b r o s i s p a t i e n t s , ges 8 t o 14 y e a r s i n a metabolic u n i t . Uletary i n t a k e was f i x e o r the e n t i r e study e r i o d f o r each p a t i e n t !.!can i n t a k e of ca r i e s was 81 ~c a l / K g j c ; , f a t 2.7 Gm/Kg/u and p r o t e i n 3.0 Gm/Kq/d. dosage l e v e l s of each p r e p a r a t i o n were used; V~o k a s e 4 , 8 o r 12 a b l e t s , Cotazym 2.4 o r 6 capsules and Pancrease 1.2 o r 3 capu l e s p e r m a 1 p e r met&olic period. P a t i e n t s were randomly asigned t o 1 of 2 s t u d y groups; Vlokase o r Cotazyrn vnrus I'anrease. F a t and n i t r o g e n absorptions were s i q n i f l c a n t l y i nreased on each p r e p a r a t i o n over the placebo.
But no s i q n i f r c a n i f f e r e n c e i n absorption was noted between t h e 3 p r e p a r a t i o n s a t a u l dosage l e v e l . T h e r e s u l t s of t h i s s t u u v I n d i c a t e t h a t P.mr e a s e , a pll sensitive e n t e r i c coated microspherules p a n c r e a t i n r e p a r a t i o n 1s a s e f f e c t i v e a s Vlokase and Cotaym, b u t a t s i q n i c a n t l y lower enzyme doses. 
